ENOGIVA Trademark

Trademark Overview

On Thursday, May 22, 2014, a trademark application was filed for ENOGIVA with the United States Patent and Trademark Office. The USPTO has given the ENOGIVA trademark a serial number of 86288799. The federal status of this trademark filing is REGISTERED as of Tuesday, March 27, 2018. This trademark is owned by Glaxo Group Limited. The ENOGIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
enogiva

General Information

Serial Number86288799
Word MarkENOGIVA
Filing DateThursday, May 22, 2014
Status700 - REGISTERED
Status DateTuesday, March 27, 2018
Registration Number5430686
Registration DateTuesday, March 27, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 4, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, March 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, November 8, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 27, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 1, 2017CASE RETURNED TO EXAMINATION
Friday, December 1, 2017NOTICE OF ALLOWANCE CANCELLED
Thursday, November 30, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, November 29, 2017ASSIGNED TO PETITION STAFF
Tuesday, November 14, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, June 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017SOU EXTENSION 5 GRANTED
Tuesday, June 6, 2017SOU EXTENSION 5 FILED
Tuesday, June 13, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 6, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 10, 2016SOU EXTENSION 4 GRANTED
Thursday, December 1, 2016SOU EXTENSION 4 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Thursday, November 3, 2016ASSIGNED TO EXAMINER
Tuesday, July 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 16, 2016SOU EXTENSION 3 GRANTED
Friday, May 27, 2016SOU EXTENSION 3 FILED
Thursday, July 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 27, 2016TEAS EXTENSION RECEIVED
Wednesday, December 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 8, 2015SOU EXTENSION 2 GRANTED
Monday, November 16, 2015SOU EXTENSION 2 FILED
Monday, December 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 16, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, May 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 30, 2015SOU EXTENSION 1 GRANTED
Thursday, April 30, 2015SOU EXTENSION 1 FILED
Thursday, April 30, 2015TEAS EXTENSION RECEIVED
Tuesday, December 9, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 6, 2014ASSIGNED TO EXAMINER
Wednesday, June 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 26, 2014NEW APPLICATION ENTERED

Related Keywords

enogiva pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological